DSM Capital Partners LLC bought a new stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 371 shares of the medical research company’s stock, valued at approximately $28,000. Other institutional investors and hedge […]